Stock listing
Instil Bio, Inc.
Selected listing: TIL · NASDAQ · USD · US
Instil Bio, Inc. (NASDAQ:TIL), Health Technology. Latest release Aug 13, 2026: Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate…
- Ticker
- NASDAQ:TIL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Instil Bio, Inc.
Instil Bio, Inc. is a public company traded under the ticker TIL in the American market. Instil Bio focuses on developing innovative cell therapies for cancer treatment.
Latest news from Instil Bio, Inc.
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 26, 2026
Instil Bio’s Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco
January 6, 2026
Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
Research Instil Bio, Inc.
Alternate listings
TIL:BOATS
US · USD
Alternate listing for Instil Bio, Inc.; the primary context on this page is TIL:NASDAQ.
5GT0:TRADEGATE
DE · EUR
Alternate listing for Instil Bio, Inc.; the primary context on this page is TIL:NASDAQ.
5GT0:FWB
DE · EUR
Alternate listing for Instil Bio, Inc.; the primary context on this page is TIL:NASDAQ.